Learning Outcomes of “GetSMART,” Education for Diagnostics and Targeted Treatment for HER2+ Metastatic Gastric and Colorectal Cancers
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Learning Outcomes of “GetSMART,” Education for Diagnostics and Targeted Treatment for HER2+ Metastatic Gastric and Colorectal Cancers ; day:23 ; month:12 ; year:2023 ; pages:1-8
Journal of cancer education ; (23.12.2023), 1-8
- Urheber
-
Augustyniak, Monica
Lou, Emil
Jacobs, Ginny
Fleming, Matthew
Marshall, John
Coutinho, Anelisa
Yoshino, Takayuki
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s13187-023-02384-8
- URN
-
urn:nbn:de:101:1-2024030721035556637851
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:52 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Augustyniak, Monica
- Lou, Emil
- Jacobs, Ginny
- Fleming, Matthew
- Marshall, John
- Coutinho, Anelisa
- Yoshino, Takayuki
- SpringerLink (Online service)
Ähnliche Objekte (12)
Contextual reprogramming of CAR-T cells for treatment of HER2+ cancers
Special Issue : Emerging Technologies for Medical Imaging Diagnostics, Monitoring and Therapy of Cancers
Synthetic lethality between HER2 and transaldolase in intrinsically resistant HER2-positive breast cancers
Different mechanisms for resistance to trastuzumab versus lapatinib in HER2- positive breast cancers - role of estrogen receptor and HER2 reactivation
Evaluation of Next Generation Sequencing for Detecting HER2 Copy Number in Breast and Gastric Cancers
Outcomes of Pemetrexed-based chemotherapies in HER2-mutant lung cancers
Endophilin A2 promotes HER2 internalization and sensitivity to trastuzumab-based therapy in HER2-positive breast cancers
Biosensors for environmental diagnostics
Diagnostics for rare diseases
Integrating diagnostics for elimination
Affordable diagnostics for Africa
Affordable diagnostics for Africa
Contextual reprogramming of CAR-T cells for treatment of HER2+ cancers
Special Issue : Emerging Technologies for Medical Imaging Diagnostics, Monitoring and Therapy of Cancers
Synthetic lethality between HER2 and transaldolase in intrinsically resistant HER2-positive breast cancers
Different mechanisms for resistance to trastuzumab versus lapatinib in HER2- positive breast cancers - role of estrogen receptor and HER2 reactivation
Evaluation of Next Generation Sequencing for Detecting HER2 Copy Number in Breast and Gastric Cancers
Outcomes of Pemetrexed-based chemotherapies in HER2-mutant lung cancers
Endophilin A2 promotes HER2 internalization and sensitivity to trastuzumab-based therapy in HER2-positive breast cancers
Biosensors for environmental diagnostics
Diagnostics for rare diseases
Integrating diagnostics for elimination
Affordable diagnostics for Africa
Affordable diagnostics for Africa
Contextual reprogramming of CAR-T cells for treatment of HER2+ cancers
Special Issue : Emerging Technologies for Medical Imaging Diagnostics, Monitoring and Therapy of Cancers
Synthetic lethality between HER2 and transaldolase in intrinsically resistant HER2-positive breast cancers
Different mechanisms for resistance to trastuzumab versus lapatinib in HER2- positive breast cancers - role of estrogen receptor and HER2 reactivation
Evaluation of Next Generation Sequencing for Detecting HER2 Copy Number in Breast and Gastric Cancers
Outcomes of Pemetrexed-based chemotherapies in HER2-mutant lung cancers
Endophilin A2 promotes HER2 internalization and sensitivity to trastuzumab-based therapy in HER2-positive breast cancers
Biosensors for environmental diagnostics
Diagnostics for rare diseases
Integrating diagnostics for elimination
Affordable diagnostics for Africa